Directory
>
Lev Verkh
Lev Verkh
Chief Regulatory and Clinical Development Officer | Stemedica Cell Technologies, Inc
Escondido, California, United States
Lev Verkh
Summary
Lev Verkh is a seasoned professional with over 22 years of experience in clinical research and development, specializing in biotechnology and clinical trials. He has a strong track record in designing and conducting Phase 1 through Phase 4 studies, with notable expertise in oncology, cardiology, and hematology. His extensive experience includes preparing regulatory submissions such as IND, NDA, and MAA, and he has worked closely with major regulatory authorities including the FDA and EMEA. Lev has held leadership roles at organizations like Stemedica and Pfizer, where he was instrumental in managing complex clinical trials. His academic background includes a Ph.D. in Biophysics from the University at Buffalo. Lev is passionate about advancing medical research and improving patient outcomes through innovative clinical practices.
Lev Verkh
Work Experience
Chief Regulatory and Clinical Development Officer at
Stemedica Cell Technologies, Inc
June 2010 - Present
Contractor at
Pfizer, Inc.
October 2004 - Present
Contractor at
ClinForce
October 2004 - Present
Contractor at
Baxter Biosciences Los Angeles
January 2002 - January 2004
Lev Verkh
Education
University at Buffalo, Ph.D.
January 1976 - January 1985
Frequently Asked Questions about Lev Verkh
What is Lev Verkh email address?
Lev Verkh's primary email address is ******@stemedica.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Lev Verkh work for?
Lev Verkh is a Chief Regulatory and Clinical Development Officer at Stemedica Cell Technologies, Inc, a company specializing in Commercial physical research.
Where Lev Verkh graduated from?
Lev Verkh holds a degree in Biophysics from University at Buffalo.
How can I directly contact Lev Verkh?
To contact Lev Verkh directly, you can use the email address ******@stemedica.com. Complete contact information is available upon registration with Muraena.
Who is Lev Verkh?
Lev Verkh is a seasoned professional with over 22 years of experience in clinical research and development, specializing in biotechnology and clinical trials. He has a strong track record in designing and conducting Phase 1 through Phase 4 studies, with notable expertise in oncology, cardiology, and hematology. His extensive experience includes preparing regulatory submissions such as IND, NDA, and MAA, and he has worked closely with major regulatory authorities including the FDA and EMEA. Lev has held leadership roles at organizations like Stemedica and Pfizer, where he was instrumental in managing complex clinical trials. His academic background includes a Ph.D. in Biophysics from the University at Buffalo. Lev is passionate about advancing medical research and improving patient outcomes through innovative clinical practices.
Lev`s contact details
******@stemedica.com
Colleagues
Chief Medical Officer
Legate
Vice Chairman Of The Board
Vice President, Clinical Development
Chief Regulatory & Clinical Development Officer
Chief Technology Officer
Corporate Secretary
Vice President, Investor Relations